Alliance Pharma
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	£163.20M N/A	£167.41M 2.57%	£180.68M 7.92%	Avg: £204.54M Low: £193.91M High: £213.50M avg. 13.20%	Avg: £213.06M Low: £203.27M High: £221.29M avg. 4.16%	Avg: £214M Low: £204.17M High: £222.27M avg. 0.44%
Net Income % change YoY	£7.31M N/A	£936K -87.21%	£-33.13M -3640.17%	Avg: £20.2M Low: £17.01M High: £23.76M avg. 160.96%	Avg: £22.9M Low: £21.92M High: £23.76M avg. 13.36%	Avg: £36.08M Low: £33.92M High: £37.89M avg. 57.56%
EBITDA % change YoY	£43.56M N/A	£20.75M -52.36%	£-28.94M -239.46%	Avg: £52.84M Low: £50.09M High: £55.16M avg. 282.57%	Avg: £55.04M Low: £52.51M High: £57.17M avg. 4.16%	Avg: £55.28M Low: £52.74M High: £57.42M avg. 0.44%
EPS % change YoY	$0.01 N/A	$0 -87.59%	-$0.06 -3705.88%	Avg: $0.04 Low: $0.03 High: $0.04 avg. 160.84%	Avg: $0.04 Low: $0.04 High: $0.04 avg. 13.40%	Avg: $0.07 Low: $0.06 High: $0.07 avg. 57.91%
Operating Expenses % change YoY	£81.72M N/A	£72.88M -10.82%	£143.46M 96.84%	Avg: £73.52M Low: £69.70M High: £76.74M avg. -48.75%	Avg: £76.58M Low: £73.06M High: £79.54M avg. 4.16%	Avg: £76.92M Low: £73.38M High: £79.89M avg. 0.44%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 77.29% in 2025-2027.

We have gathered data from 5 analysts. Their low estimate is 17.01M, average is 20.2M and high is 23.76M.

Wall Street analysts forecast annual average revenue growth of 5.93% in 2025-2027.

We have gathered data from 6 analysts. Their low revenue estimate is £193.91M, average is £204.54M and high is £213.50M.

Wall Street analysts forecast annual average earnings growth of 77.39% in 2025-2027.

We have gathered data from 5 analysts. Their low earnings per share estimate is $0.03, average is $0.04 and high is £0.04.